Development of lysosomal storage in mice with targeted disruption of the β-galactosidase gene: a model of human GM1-gangliosidosis
- 31 October 2001
- journal article
- Published by Elsevier BV in Brain & Development
- Vol. 23 (6), 379-384
- https://doi.org/10.1016/s0387-7604(01)00244-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Degradative Pathway of Gangliosides GM1 and GM2 in Neuro2a Cells by SialidaseJournal of Neurochemistry, 2002
- Mouse Models of Human Lysosomal DiseasesBrain Pathology, 1998
- Generalized CNS Disease and Massive GM1-Ganglioside Accumulation in Mice Defective in Lysosomal Acid -galactosidaseHuman Molecular Genetics, 1997
- Neurological manifestations of knockout mice with β-galactosidase deficiencyBrain & Development, 1997
- β-Galactosidase-deficient mouse as an animal model for GM1-gangliosidosisGlycoconjugate Journal, 1997
- Developmental changes of ganglioside expressions in postnatal rat cerebellar cortexBrain Research, 1995
- Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolismNature Genetics, 1995
- Neuropathology of mice with targeted disruption of Hexa gene, a model of Tay-Sachs diseaseActa Neuropathologica, 1995
- Pathologic Findings in Fetal GM1 GangliosidosisArchives of Neurology, 1986
- GM1-gangliosidosis: Chromosome 3 assignment of the?-galactosidase-A gene (? GAL A )Somatic Cell and Molecular Genetics, 1979